Literature DB >> 12807932

Dose-intense paclitaxel: deja vu all over again?

Chris H Takimoto, Eric K Rowinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12807932     DOI： 10.1200/JCO.2003.05.099

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  Maximum tolerated dose: clinical endpoint for a bygone era?

Authors:  Chris H Takimoto
Journal:  Target Oncol       Date:  2009-04-18       Impact factor: 4.493

2.  A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.

Authors:  Stephen K Williamson; Gary A Johnson; Holly A Maulhardt; Kathleen M Moore; D S McMeekin; Thomas K Schulz; Gregory A Reed; Katherine F Roby; Christine B Mackay; Holly J Smith; Scott J Weir; Jo A Wick; Maurie Markman; Gere S diZerega; Michael J Baltezor; Jahna Espinosa; Charles J Decedue
Journal:  Cancer Chemother Pharmacol       Date:  2015-04-23       Impact factor: 3.333

3.  Pretreatment of Shaoyao Gancao Decoction () alters pharmacokinetics of intravenous paclitaxel in rats.

Authors:  Yang Wang; Xi Huang; Mei-Zuo Zhong; Ruo-Huang Lu; Zi-An Xia; Rong Fan; Bo Liu; Wei Huang; Ping-Ping Gan
Journal:  Chin J Integr Med       Date:  2016-09-27       Impact factor: 1.978

4.  Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery.

Authors:  A R Tzafriri; A D Levin; E R Edelman
Journal:  Cell Prolif       Date:  2009-03-31       Impact factor: 6.831

5.  Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.

Authors:  Anjaiah Srirangam; Ranjana Mitra; Mu Wang; J Christopher Gorski; Sunil Badve; LeeAnn Baldridge; Justin Hamilton; Hiromitsu Kishimoto; John Hawes; Lang Li; Christie M Orschell; Edward F Srour; Janice S Blum; David Donner; George W Sledge; Harikrishna Nakshatri; David A Potter
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

6.  Clinical trials and progress with paclitaxel in ovarian cancer.

Authors:  Sanjeev Kumar; Haider Mahdi; Christopher Bryant; Jay P Shah; Gunjal Garg; Adnan Munkarah
Journal:  Int J Womens Health       Date:  2010-11-19

7.  The Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer-Hyperthermia versus Normothermia: A Randomized Controlled Trial.

Authors:  Angela Casado-Adam; Lidia Rodriguez-Ortiz; Sebastian Rufian-Peña; Cristobal Muñoz-Casares; Teresa Caro-Cuenca; Rosa Ortega-Salas; Maria Auxiliadora Fernandez-Peralbo; Maria Dolores Luque-de-Castro; Juan M Sanchez-Hidalgo; Cesar Hervas-Martinez; Antonio Romero-Ruiz; Javier Briceño; Álvaro Arjona-Sánchez
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.